Research programme: autoimmune disorders - GMP Immunotherapeutics/University of Michigan
Alternative Names: Autoimmune disorders research programme - GMP Immunotherapeutics/University of MichiganLatest Information Update: 04 Jan 2007
Price :
$50 *
At a glance
- Originator University of Michigan
- Class
- Mechanism of Action Apoptosis stimulants; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders; Cancer
Most Recent Events
- 04 Jan 2007 Discontinued - Preclinical for Autoimmune disorders in USA (unspecified route)
- 04 Jan 2007 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 12 Dec 2003 Preclinical trials in Autoimmune disorders in USA (unspecified route)